Spravato (Esketamine)
Spravato (Esketamine) –
· FDA-approved treatment for major depressive disorder (specifically for depression that has not responded well to antidepressants) since 2019
· Administered via nasal spray
· Covered by all commercial insurances and Medicare.
· Requires in-office treatments:
o Twice weekly for four weeks, then
o Once weekly for four weeks, then
o Continued weekly treatments or every other week treatments for maintenance
· Individual treatment duration: 2 hours (nasal spray administered, then 2 hour monitoring period)
· Restrictions: Cannot drive for rest of day after treatment
Pros:
· One of the most effective treatments for depression that exists - 50% remission rate (depression resolved), 75% response rate (over 50% improvement)
· Independently effective and reducing suicidal thoughts, aside from its profound effect in treating depression
· Ketamine (although not spravato specifically) has been found to be very effective for treating not only depression, but also for anxiety disorders and PTSD.
· Vast majority of side effects wash out completely within two hours) and no significant side effects thereafter. No long-term side effects.
· Covered by insurance
Cons:
· Maintenance treatment is required to maintain the benefit of the medication
· Cannot drive for rest of the day after a treatment
Process:
· Schedule consultation with our neuromodulation expert, Dr. Ahmed
· If determined to be a good candidate, start treatment in about 2-3 weeks